Patient adherence continues to be a very real obstacle to attaining positive outcomes for those with chronic conditions, such as autoimmune diseases and diabetes. Non-compliance, as we know, can result in poor clinical outcomes for patients. However, it can also mean lost revenue for pharmaceutical companies worldwide and increased costs for many stakeholders in healthcare,…